Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metabolic ammonia handling pathways represent the collective biochemical systems responsible for the detoxification and excretion of ammonia, a neurotoxic byproduct of protein metabolism. The central component is the urea cycle, a series of five enzymatic reactions in the liver—including carbamoyl phosphate synthetase I and ornithine transcarbamylase—that convert ammonia into water-soluble urea for renal excretion (StatPearls, 2023). Secondary pathways involve the synthesis of glutamine by glutamine synthetase in the brain, muscle, and liver, as well as the transport of ammonia across cell membranes via Rh glycoproteins (PubMed, 2018). Impairment of these pathways, whether due to genetic defects (urea cycle disorders) or acquired liver disease (cirrhosis), leads to hyperammonemia, which can cause life-threatening cerebral edema and hepatic encephalopathy (NIH, 2022). Therapeutic strategies focus on reducing the ammonia load through nitrogen-scavenging agents that provide alternative excretion routes or by using antibiotics and osmotic laxatives to decrease ammonia production in the gastrointestinal tract (Journal of Hepatology, 2019).
Drugs targeting these pathways function by scavenging excess nitrogen through alternative metabolic routes (e.g., phenylbutyrate forming phenylacetylglutamine), reducing ammonia production by enteric bacteria (e.g., rifaximin, lactulose), or providing essential intermediates and enzyme activators to restore urea cycle flux (e.g., carglumic acid, arginine).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metabolic ammonia handling pathways.